SCHEMBL24578461

SCHEMBL24578461

Cc1ncc(NC(=O)CN2CCCC2)cc1NC(=O)c1cnn2cc(Br)sc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PARP1 P09874 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ WNT1 P04628 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ TERT O14746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27185105 0.99 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1RAB9ANPC1
SCHEMBL29759947 0.99 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1RAB9ANPC1
SCHEMBL29760165 0.99 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1RAB9ANPC1
SCHEMBL24577941 0.99 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1RAB9ANPC1
SCHEMBL29759935 0.98 ALDH1A1 (0.39) ALDH1A1KDM4ETDP1RAB9ANPC1
SCHEMBL24579109 0.98 ALDH1A1 (0.39) ALDH1A1KDM4ETDP1RAB9ANPC1
SCHEMBL24577897 0.91 WNT1 (0.39) ALDH1A1KDM4ETDP1LMNAMAPT
SCHEMBL29759637 0.91 WNT1 (0.39) ALDH1A1KDM4ETDP1LMNAMAPT
SCHEMBL24577265 0.90 WNT1 (0.37) WNT1GSK3BDYRK1A
SCHEMBL29759530 0.90 POLB (0.34) ALDH1A1RAB9ANPC1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback